IceCure Medical Ltd. (NASDAQ:ICCM – Get Free Report) was the target of a large drop in short interest in July. Get IceCure Medical alerts:IceCure Medical Stock Down 3.1%NASDAQ:ICCM traded down $0.09 on Tuesday, reaching $2.79. IceCure Medical had a negative return on equity of 211.73% and a negative net margin of 441.60%. Originally founded in Israel, IceCure Medical obtained its first CE mark for the treatment of benign breast tumors and fibroadenomas in 2017. Featured StoriesReceive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.